Dianthus Therapeutics Statistics
Total Valuation
DNTH has a market cap or net worth of $820.50 million. The enterprise value is $430.83 million.
Important Dates
The next estimated earnings date is Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
DNTH has 29.37 million shares outstanding. The number of shares has increased by 413.54% in one year.
Shares Outstanding | 29.37M |
Shares Change (YoY) | +413.54% |
Shares Change (QoQ) | +33.36% |
Owned by Insiders (%) | 0.22% |
Owned by Institutions (%) | 55.68% |
Float | 13.41M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 134.85 |
Forward PS | 484.71 |
PB Ratio | 2.21 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 104.62 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 36.46, with a Debt / Equity ratio of 0.00.
Current Ratio | 36.46 |
Quick Ratio | 36.13 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.33% and return on invested capital (ROIC) is -20.67%.
Return on Equity (ROE) | -27.33% |
Return on Assets (ROA) | -19.84% |
Return on Capital (ROIC) | -20.67% |
Revenue Per Employee | $77,698 |
Profits Per Employee | -$1.07M |
Employee Count | 53 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +130.34% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +130.34% |
50-Day Moving Average | 27.82 |
200-Day Moving Average | 25.22 |
Relative Strength Index (RSI) | 51.22 |
Average Volume (20 Days) | 247,483 |
Short Selling Information
The latest short interest is 4.97 million, so 16.94% of the outstanding shares have been sold short.
Short Interest | 4.97M |
Short Previous Month | 4.33M |
Short % of Shares Out | 16.94% |
Short % of Float | 37.10% |
Short Ratio (days to cover) | 25.83 |
Income Statement
In the last 12 months, DNTH had revenue of $4.12 million and -$56.68 million in losses. Loss per share was -$2.75.
Revenue | 4.12M |
Gross Profit | 4.12M |
Operating Income | -68.76M |
Pretax Income | -56.68M |
Net Income | -56.68M |
EBITDA | -68.68M |
EBIT | -68.76M |
Loss Per Share | -$2.75 |
Full Income Statement Balance Sheet
The company has $360.71 million in cash and $407,000 in debt, giving a net cash position of $360.30 million or $12.27 per share.
Cash & Cash Equivalents | 360.71M |
Total Debt | 407,000 |
Net Cash | 360.30M |
Net Cash Per Share | $12.27 |
Equity (Book Value) | 358.22M |
Book Value Per Share | 12.20 |
Working Capital | 355.66M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$51.32 million and capital expenditures -$124,000, giving a free cash flow of -$51.44 million.
Operating Cash Flow | -51.32M |
Capital Expenditures | -124,000 |
Free Cash Flow | -51.44M |
FCF Per Share | -$1.75 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -1,669.82% |
Pretax Margin | -1,376.42% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -635.79% |
Dividends & Yields
DNTH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -413.54% |
Shareholder Yield | -413.54% |
Earnings Yield | -7.16% |
FCF Yield | -6.50% |
Analyst Forecast
The average price target for DNTH is $45.14, which is 61.56% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $45.14 |
Price Target Difference | 61.56% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
DNTH has an Altman Z-Score of 26.08 and a Piotroski F-Score of 2.
Altman Z-Score | 26.08 |
Piotroski F-Score | 2 |